-
Signature
-
/s/ Christopher E French Attorney in Fact for Michael Anthony Rhymes
-
Issuer symbol
-
SHEN
-
Transactions as of
-
18 Feb 2026
-
Net transactions value
-
-$31,263
-
Form type
-
4
-
Filing time
-
20 Feb 2026, 16:13:17 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Rhymes Michael Anthony |
Director |
PO BOX 459, EDINBURG |
/s/ Christopher E French Attorney in Fact for Michael Anthony Rhymes |
20 Feb 2026 |
0002031312 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SHEN |
Common Stock |
Options Exercise |
|
+10,924 |
+343% |
|
14,112 |
18 Feb 2026 |
Direct |
F1 |
| transaction |
SHEN |
Common Stock |
Tax liability |
$31,263 |
-2,403 |
-17% |
$13.01 |
11,709 |
18 Feb 2026 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SHEN |
Restricted Stock Unit |
Options Exercise |
$0 |
-10,924 |
-100% |
$0.000000 |
0 |
18 Feb 2026 |
Common Stock |
10,924 |
|
Direct |
F1 |
| transaction |
SHEN |
Restricted Stock Unit |
Award |
$0 |
+9,863 |
|
$0.000000 |
9,863 |
19 Feb 2026 |
Common Stock |
9,863 |
|
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Michael Anthony Rhymes is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: